Caffeine Completed Phase 2 Trials for Migraine Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01080677Caffeine/Propranolol Acute Migraine